COPD

News Story

05/04/2016

Debilitating symptoms from chronic obstructive pulmonary disease (COPD) can worsen in patients who also experience depression, research suggests. Patients who had pre-existing depression or developed depression after COPD diagnosis were more likely to experience heightened COPD symptoms, such as increased breathlessness, reduced exercise tolerance and hopelessness.More »

03/15/2016

Beta-blockers could be used to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations, according to new research findings.More »

10/05/2015

Researchers are raising safety concerns about high rates of new opioid use among older adults with COPD, according to a study. Opioids, such as codeine, oxycodone and morphine might be prescribed more frequently among older adults with COPD to treat chronic muscle pain, breathlessness and insomnia. Common side effects of opioids include falls and fractures, confusion, memory impairment, fatigue, constipation, nausea, vomiting and abdominal pain.More »

COPD, opoids
04/17/2014

A group of drugs commonly prescribed for insomnia, anxiety and breathing issues "significantly increase the risk" that older people with chronic obstructive pulmonary disease, or COPD, need to visit a doctor or Emergency Department for respiratory reasons, new research has found.More »

09/10/2013

An international study led by a Johns Hopkins pulmonary expert finds that the drug tiotropium (marketed as the Spiriva brand), can be delivered safely and effectively to people with chronic obstructive pulmonary disease (COPD) in both "mist" and traditional "dry powder" inhalers.More »

03/25/2013

The antibiotic clarithromycin -- widely used for treating lower respiratory tract infections like pneumonia and acute exacerbations (sudden worsening) of chronic obstructive pulmonary disease (COPD) -- may be associated with an increased risk of heart problems, finds a new study.More »

02/07/2013

A popular class of drugs commonly used to treat sleep and mood symptoms continues to be frequently prescribed despite being known to have potentially life-threatening side effects.More »

09/10/2012

Antibiotic treatment with amoxicillin/clavulanate improves moderate exacerbations in patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) and significantly prolongs the time between exacerbations, according to a new study from researchers in Spain.More »

antibiotics, COPD
02/09/2012

A new study published in the journal Respirology reveals that a high level of soft drink consumption is associated with asthma and/or chronic obstructive pulmonary disease (COPD).

Led by Zumin Shi, MD, PhD, of the University of Adelaide, researchers conducted computer assisted telephone interviewing among 16,907 participants aged 16 years and older in South Australia between March 2008 and June 2010 inquiring about soft drink consumption. Soft drinks comprised Coke, lemonade, flavored mineral water, Powerade, and Gatorade etc.More »

08/26/2011

Adding a common antibiotic to the usual daily treatment regimen for chronic obstructive pulmonary disease (COPD) can reduce the occurrence of acute exacerbations and improve quality of life, reports new results from a clinical trial funded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

The study appears in the Aug. 25 issue of the New England Journal of Medicine.More »

1 of 2

Syndicate content